Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers World Congress 2016

Peter Quesenberry's Biography

Peter Quesenberry, Professor of Medicine, The Warren Alpert Medical School of Brown University

Dr Peter Quesenberry is a hematologist/oncologist with a long history of work on stem cell biology and characteristics of the stem cell, especially with regard to cell cycle transit. More recently his work has focused on extracellular vesicles and their capacity to alter cell fate and to restore injured tissue. Dr Quesenberry is the Paul Calabresi, MD Professor in Oncology and Director of Hematology/Oncology Research at the Warren Alpert Medical School of Brown University. He lists over 300 publications on PubMed. He is the American editor of the Journal of Extracellular Vesicles.

Peter  Quesenberry Image

Extracellular Vesicles as Biologic Modifiers

Tuesday, 22 March 2016 at 10:00

Add to Calendar ▼

Extracellular vesicles are produced by essentially all tissues. Their nature is predicated by the nature of the originator cells, the treatment of the originator cells, the nature of the target cells and the type of initial vesicle separation. Vesicles have been shown to have deleterious or beneficial effects in different settings. If the vesicles derive from damaged or diseased tissue the effects are generally to make the situation worse, this is seen in cancer and pulmonary hypertension models. However, if the vesicles derive from normal tissues or mesenchymal stem cells healing effects are generally seen. Based on a number of studies it would appear that initial biologic effects of vesicles are due to transfer of mRNA and transcriptional regulators but long term effects are due to transcriptional modifications. Different studies have shown reversion of renal injury and radiation induced marrow injury with mesenchymal stem cell derived vesicles. The vesicles largely consist of exosomes and microvesicles which may be differently active in different models. The functional effects are stable on long term storage in 10% DMSO. Overall, administration of extracellular vesicles represent promising therapeutic approaches for a number of tissue injuries or diseases.

Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonCirculating Biomarkers World Congress 2016Circulating Biomarkers World Congress 2016 in Boston, USABoston,